Loading clinical trials...
Loading clinical trials...
Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance: Prospective, Randomized, Open, Blinded Outcome Evaluation, and Feasibility Trial
Conditions
Interventions
Behavioral intensification
Pharmacological intensification based on olmesartan
+1 more
Locations
3
South Korea
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Nowon Eulji Medical Center, Eulji University
Seoul, South Korea
Seoul Medical Center
Seoul, South Korea
Start Date
September 1, 2016
Primary Completion Date
December 7, 2017
Completion Date
December 7, 2017
Last Updated
April 6, 2018
NCT02417740
NCT07371455
NCT07253181
NCT07480265
NCT07073820
NCT06876233
Lead Sponsor
Seoul National University Bundang Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions